SEC Form 4 · accession 0001193125-26-340260
SHOULDER INNOVATIONS, INC. · SI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gilde Healthcare Holding B.V.
10% Owner
Period of report
Aug 5, 2026
Accepted (ET)
Aug 7, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001699350
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 5, 2026 | S | 7,338 | $22.64 | D | 2,214,302 | I | See footnote |
| Common StockF2 | Aug 6, 2026 | S | 2,095 | $22.60 | D | 2,212,207 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This figure is the weighted average sales price of multiple trades ranging from $22.60 to $23.00 per share. The Reporting Person undertakes to provide the Staff of the Securities and Exchange Commission, Shoulder Innovations, Inc. or any security holder of Shoulder Innovations, Inc. full information about the number of shares sold at each separate price upon request.
- F2Held directly by Cooperatieve Gilde Healthcare V U.A. ("Gilde"). Gilde Healthcare V Management B.V. is the managing director of Gilde and has sole voting and dispositive power with respect to the shares held by Gilde. Gilde Healthcare V Management B.V. is owned by Gilde Healthcare Holding B.V. The managing partners of Gilde Healthcare Holding B.V. are Manapouri B.V. (of which Edwin de Graaf is the owner and managing director) and Martemanshurk B.V. (of which Pieter van der Meer is the owner and managing director). Geoff Pardo is a partner at Gilde and may be deemed to share voting and dispositive power with respect to the shares held of record by Gilde. Mr. Pardo disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.